FDA 483 OBSERVATION · #144 OF 1,923 MOST-CITED
Toxic chemicals - Identified, held, stored
FDA cited this observation 210 times across 199 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Toxic cleaning compounds, sanitizing agents, and pesticide chemicals were not identified, held, and stored in a manner that protects against contamination of food, food-contact surfaces, and packaging — for example unlabeled containers or chemicals stored near or above exposed product.
Why FDA writes it — Cleaning chemicals, sanitizers, and pesticides are toxic by design; if they are unlabeled or stored where they can spill, drift, or be mistaken for a food ingredient, they cause chemical contamination and adulteration that harms consumers directly.
- Label every chemical container clearly with its identity and keep only chemicals necessary to the operation.
- Store toxic cleaning, sanitizing, and pesticide chemicals in a designated area segregated from food and packaging.
- Restrict chemicals to trained, authorized personnel and control access to the storage area.
- Keep and follow current safety data sheets and use instructions for each chemical held on site.
- Chemicals are decanted into unlabeled secondary containers, defeating identification at the point of use.
- No dedicated, segregated chemical store exists, so cleaning agents and pesticides end up near production materials.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.1× the rate of the average FDA-cited firm (8.5% vs 7.8%), across 199 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
You did not identify a toxic chemical in a manner that protects against contamination.
You did not store a toxic chemical in a manner that protects against contamination.
You did not identify a toxic chemical in a manner that protects against contamination.
You did not identify a toxic chemical in a manner that protects against contamination.
You did not hold a toxic chemical in a manner that protects against contamination.
You did not identify a toxic chemical in a manner that protects against contamination.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →